Ad hoc announcement pursuant to Art. 53 LR – CREALOGIX sales fell by 14% to CHF 94 million in the challenging financial year 2021/22. This drop in sales, together with the extraordinarily high capital investment for the implementation of the development bank product in Germany led to a negative EBITDA of CHF 9.3 million. The implemented cost reductions and the conclusion of the investment in the development bank product will ensure a rapid return to positive EBITDA in the financial year 2022/23.
Annual General Meeting (AGM)
Presentation half-year results 2022/2023
Annual Results 2021/2022
SaaS share up to
Revenues in CHF